Differential glycosylation of MUC1 and CEACAM5 between normal mucosa and tumour tissue of colon cancer patients
Open Access
- 5 August 2011
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 131 (1), 117-128
- https://doi.org/10.1002/ijc.26354
Abstract
Altered glycosylation in epithelial cancers may play an important role in tumour progression, as it may affect tumour cell migration and antigen presentation by antigen presenting cells. We specifically characterise the glycosylation patterns of two tumour antigens that are highly expressed in cancer tissue and often detected in their secreted form in serum: the epithelial mucin MUC1 and carcinoembryonic antigen (CEA, also called CEACAM5). We analysed 48 colorectal cancer patients, comparing normal colon and tumour epithelium within each patient. Lectin binding was studied by a standardised CEA/MUC1 capture ELISA, using several plant lectins, and the human C-type lectins MGL and DC-SIGN, and Galectin-3. Peanut agglutinin (PNA) bound to MUC1 from tumour tissue in particular, suggests increased expression of the Thomsen-Friedenreich antigen (TF-antigen) (Core 1, Galβ1-3GalNAc-Ser/Thr). Only small amounts of Tn-antigen (GalNAcα-Ser/Thr) expression was observed, but the human C-type lectin MGL showed increased binding to tumour-associated MUC1. Furthermore, sialylation was greatly enhanced. In sharp contrast, tumour-associated CEA (CEACAM5) contained high levels of the blood-group related carbohydrates, Lewis X and Lewis Y. This correlated strongly with the interaction of the human C-type lectin DC-SIGN to tumour-associated CEA, suggesting that CEA can be recognized and taken up by antigen presenting cells. In addition, increased mannose expression was observed and branched N-glycans were prominent, and this correlated well with human Galectin-3 binding. These data demonstrate that individual tumour antigens contain distinct glycan structures associated with cancer and, since glycans affect cellular interactions with its microenvironment, this may have consequences for progression of the disease.This publication has 42 references indexed in Scilit:
- Interaction between circulating galectin-3 and cancer-associated MUC1 enhances tumour cell homotypic aggregation and prevents anoikisMolecular Cancer, 2010
- The Bisecting GlcNAc on N-Glycans Inhibits Growth Factor Signaling and Retards Mammary Tumor ProgressionCancer Research, 2010
- Regulation of expression and secretion of galectin-3 in human monocyte-derived dendritic cellsMolecular Immunology, 2009
- The high affinity selectin glycan ligand C2-O-sLex and mRNA transcripts of the core 2 β-1,6-N-acetylglusaminyltransferase (C2GnT1) gene are highly expressed in human colorectal adenocarcinomasBMC Cancer, 2009
- Galectin-1, -2, and -3 Exhibit Differential Recognition of Sialylated Glycans and Blood Group AntigensOnline Journal of Public Health Informatics, 2008
- Specificity of DC‐SIGN for mannose‐ and fucose‐containing glycansFEBS Letters, 2006
- Autoproteolysis coupled to protein folding in the SEA domain of the membrane-bound MUC1 mucinNature Structural & Molecular Biology, 2005
- The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissuesSeminars in Cancer Biology, 1999
- Distribution of Tn antigen recognized by an anti-Tn monoclonal antibody (MLS128) in normal and malignant tissues of the digestive tractZeitschrift für Krebsforschung und Klinische Onkologie, 1995
- Difference in the ability of blood group-specific lectins and monoclonal antibodies to recognize the ABH antigens in human tissuesJournal of Molecular Histology, 1990